Mark Fitzpatrick
2013 - Aegerion Pharmaceuticals
In 2013, Mark Fitzpatrick earned a total compensation of $1.9M as former Chief Financial Officer at Aegerion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $203,000 |
|---|---|
| Option Awards | $1,327,839 |
| Salary | $350,000 |
| Other | $7,650 |
| Total | $1,888,489 |
Fitzpatrick received $1.3M in option awards, accounting for 70% of the total pay in 2013.
Fitzpatrick also received $203K in non-equity incentive plan, $350K in salary and $7.7K in other compensation.
Rankings
In 2013, Mark Fitzpatrick's compensation ranked 4,087th out of 12,286 executives tracked by ExecPay. In other words, Fitzpatrick earned more than 66.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,087 out of 12,286 | 67th |
Division Manufacturing | 1,388 out of 4,612 | 70th |
Major group Chemicals And Allied Products | 378 out of 1,462 | 74th |
Industry group Drugs | 264 out of 1,156 | 77th |
Industry Pharmaceutical Preparations | 215 out of 890 | 76th |
Source: SEC filing on April 29, 2016.
Fitzpatrick's colleagues
We found four more compensation records of executives who worked with Mark Fitzpatrick at Aegerion Pharmaceuticals in 2013.